Written question asked by Janet Daby (Labour) on Wednesday, 7 December 2022, in the House of Commons. It was due for an answer on Friday, 9 December 2022. It was answered by Neil O'Brien (Conservative) on Thursday, 15 December 2022 on behalf of the Department of Health and Social Care.
Sickle Cell Diseases
- Question
-
To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the potential merits of simplifying the administration of pain relief for sickle cell patients.
- Answer
-
No specific assessment has been made.
Specialist haemoglobinopathy teams (SHTs) and haemoglobinopathy co-ordinating centres (HCCs) are required to submit data via the Specialised Services Quality Dashboard on the percentage of patients given pain relief within 30 minutes of presentation with a sickle cell crisis, as per the National Institute for Health and Care Excellence guidelines. The data does not include patients attending non-specialist haemoglobinopathy providers and further work is required to improve the accuracy of the data submission before it can be used to assess compliance.
Secondary information
- Type
- Written question
- Reference
- 105558
- Session
- 2022-23
- Related items
- Grouped for answer
- Yes
- Subjects
- Sickle cell diseases Analgesics
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-02-14 15:52:39 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/105558
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/105558
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/105558